Metabolic syndrome (MetS) and its components have been linked to elevated serum levels of inflammatory biomarkers such as C-reactive protein, interleukin-6, interleukin-1β and tumor necrosis factor alpha. The aim of our study was to address the association between MetS components with serum hs-CRP and IL-6 levels among Congolese adults. A total of 357 participants (aged 30 - 87 years) were included in this cross-sectional study. Anthropometrics were collected and fasting blood sampled for assessment of fasting blood glycaemia (FBG), lipids and inflammatory parameters using commercially available assays. NCEP-ATPIII criteria were used to define MetS. The Median (IQR) hs-CRP and IL-6 levels were higher in participants with MetS than in those without ([7 (4, 14) versus 6 (4, 8)] mg/L; p = 0.092 and [23.8 (20.9, 27.6) versus 22.3 (19.5, 25.0)] pg/mL; p = 0.002). hs-CRP and IL-6 levels were significantly higher in females with MetS than in those without, but not in males. Among participants, only TG was correlated with hs-CRP (r = 0.149, p = 0.007), and a significant correlation was observed between TG (r = 0.116, p = 0.037), FBG (r = 0.208, p = 0.000), HDL-C (r = −0.119, p = 0.034) and SBP (r = 0.143, p = 0.010) and IL-6. In males, hs-CRP levels were positively correlated with TG (0.316; p = 0.000), negatively with HDL-C (r = −0.290, p = 0.0022), without such correlations in females. In Ames, IL-6 levels were positively correlated with FBG (r = 0.202; p = 0.035), and negatively with HDL-C (r = −0.249, p = 0.009). Significant correlations between IL-6 levels and FBG (r = 0.214; p = 0.000) or SBP (r = 0.227, p = 0.000) were observed in females. Logistic regression analysis was carried out to identify the relationship between MetS components and hs-CRP or IL-6. Values of area under receiver-operating characteristic (ROC) curves suggest potential use of serum hs-CRP (AUC = 0.675) and IL-6 (AUC = 0.656) as diagnostic biomarkers of MetS. Combination of hs-CRP and IL-6 improved diagnosis accuracy, yielding a 0.698 ROC curve area. MetS components are associated with hs-CRP and IL-6 levels among adults Congolese. Combining the two biomarkers
References
[1]
Kaur, J. (2014) A Comprehensive Review on Metabolic Syndrome. Cardiology Research and Practice, 2014, Article ID: 943162. https://doi.org/10.1155/2014/943162
[2]
Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G. and Shaw, J. (2005) The Metabolic Syndrome: A Global Public Health Problem and A New Definition. Journal of Atherosclerosis and Thrombosis, 12, 295-300. https://doi.org/10.5551/jat.12.295
[3]
Huang, P.L. (2009) A Comprehensive Definition for Metabolic Syndrome. Disease Models & Mechanisms, 2, 231-237. https://doi.org/10.1242/dmm.001180
[4]
Kassi, E., Pervanidou, P., Kaltsas, G. and Chrousos, G. (2011) Metabolic Syndrome: Definitions and Controversies, BMC Medicine, 9, Article No. 48. https://doi.org/10.1186/1741-7015-9-48
[5]
Wang, H.H., Lee, D.K., Liu, M., Portincasa, P. and Wang, D.Q.-H. (2020) Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome. Pediatric Gastroenterology, Hepatology & Nutrition, 23, 189-230. https://doi.org/10.5223/pghn.2020.23.3.189
[6]
Lorenzo, C., Williams, K., Hunt, K.J. and Haffner, S.M. (2007) The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care, 30, 8-13. https://doi.org/10.2337/dc06-1414
[7]
Alberti, G., Zimmet, P., Shaw, J. and Grundy, S.M. (2006) The IDF Consensus Worldwide Definition of the Metabolic Syndrome. International Diabetes Federation, Brussels.
[8]
Liu, J., Young, T.K., Zinman, B., Harris, S.B., Connelly, P.W. and Hanley, A.J.G. (2006) Lifestyle Variables, Non-Traditional Cardiovascular Risk Factors, and the Metabolic Syndrome in an Aboriginal Canadian Population. Obesity, 14, 500-508. https://doi.org/10.1038/oby.2006.65
[9]
van Niekerk, G. and Engelbrecht, A.-M. (2018) Inflammation-Induced Metabolic Derangements or Adaptation: An Immunometabolic Perspective. Cytokine & Growth Factor Reviews, 43, 47-53. https://doi.org/10.1016/j.cytogfr.2018.06.003
[10]
Scarpellini, E. and Tack, J. (2012) Obesity and Metabolic Syndrome: An Inflammatory Condition. Digestive Diseases, 30, 148-153. https://doi.org/10.1159/000336664
[11]
León-Pedroza, J.I., González-Tapia, L.A., del Olmo-Gil, E., et al. (2015) Low-Grade Systemic Inflammation and the Development of Metabolic Diseases: From the Molecular Evidence to the Clinical Practice. Cirugía y Cirujanos (English Edition), 83, 543-551. https://doi.org/10.1016/j.circen.2015.11.008
[12]
Rexrode, K.M., Pradhan, A., Manson, J E., Buring, J.E. and Ridker, P.M. (2003) Relationship of Total and Abdominal Adiposity with CRP and IL-6 in Women. Annals of Epidemiology, 13, 674-682. https://doi.org/10.1016/S1047-2797(03)00053-X
[13]
Nishida, M., Moriyama, T., Ishii, K., et al. (2007) Effects of IL-6, Adiponectin, CRP and Metabolic Syndrome on Subclinical Atherosclerosis. Clinica Chimica Acta, 384, 99-104. https://doi.org/10.1016/j.cca.2007.06.009
[14]
Smidowicz, A. and Regula, J. (2015) Effect of Nutritional Status and Dietary Patterns on Human Serum C-Reactive Protein and Interleukin-6 Concentrations. Advances in Nutrition, 6, 738-747. https://doi.org/10.3945/an.115.009415
[15]
Li, Q., Wang, Q., Xu, W., et al. (2020) C-Reactive Protein Causes Adult-Onset Obesity Through Chronic Inflammatory Mechanism. Frontiers in Cell and Developmental Biology, 8, Article 18. https://doi.org/10.3389/fcell.2020.00018
[16]
Freeman, D.J., Norrie, J., Caslake, M.J., et al. (2002) C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51, 1596-1600. https://doi.org/10.2337/diabetes.51.5.1596
[17]
Spranger, J., Kroke, A., Mohlig, M., et al. (2003) Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes, 52, 812-817. https://doi.org/10.2337/diabetes.52.3.812
[18]
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J. and Paquot, N. (2014) Inflammation as a Link between Obesity, Metabolic Syndrome and Type 2 Diabetes. Diabetes Research and Clinical Practice, 105, 141-150. https://doi.org/10.1016/j.diabres.2014.04.006
[19]
de F Rocha, A.R., de S Morais, N., Priore, S.E. and do CC Franceschini, S. (2021) Inflammatory Biomarkers and Components of Metabolic Syndrome in Adolescents: a Systematic Review. Inflammation, 45, 14-30. https://doi.org/10.1007/s10753-021-01549-1
[20]
Christiana, U.I., Casimir, A.E., Nicholas, A.A., Christian, M.C. and Obiefuna, A.I. (2016) Plasma Levels of Inflammatory Cytokines in Adult Nigerians with the Metabolic Syndrome. Nigerian Medical Journal, 57, 64-68. https://doi.org/10.4103/0300-1652.180569
[21]
Belfki, H., Ali, S.B., Bougatef, S., et al. (2012) Relationship of C-Reactive Protein with Components of the Metabolic Syndrome in a Tunisian Population. European Journal of Internal Medicine, 23, e5-e9. https://doi.org/10.1016/j.ejim.2011.10.011
[22]
Alenad, A.M., Alkaltham, L.F., Sabico, S., et al. (2022) Associations of Zinc-α-2-Glycoprotein with Metabolic Syndrome and Its Components among Adult Arabs. Scientific Reports, 12, Article No. 4908. https://doi.org/10.1038/s41598-022-09022-1
[23]
Puzianowska-Kuźnicka, M., Owczarz, M., Wieczorowska-Tobis, K., et al. (2016) Interleukin-6 and C-Reactive Protein, Successful Aging, and Mortality: The PolSenior Study. Immunity & Ageing, 13, Article No. 21. https://doi.org/10.1186/s12979-016-0076-x
[24]
Al-Daghri, N.M., Al-Shuwaie, A.Y., Alghamdi, A., et al. (2021) Tristetraprolin, Inflammation, and Metabolic Syndrome in Arab Adults: A Case Control Study. Biology, 10, Article No. 550. https://doi.org/10.3390/biology10060550
[25]
Zafar, U., Khaliq, S., Ahmad, H.U. and Lone, K.P. (2019) Serum Profile of Cytokines and Their Genetic Variants in Metabolic Syndrome and Healthy Subjects: A Comparative Study. Bioscience Reports, 39, Article ID: BSR20181202. https://doi.org/10.1042/BSR20181202
[26]
Haddad, N.S. (2012) High Sensitivity C-Reactive Protein (hs-CRP) and Metabolic Syndrome: Correlation with Number and Type of Metabolic Syndrome Components in Iraqi Patients. The Medical Journal of Basrah University, 30, 49-54. https://doi.org/10.33762/mjbu.2012.64052
[27]
Maleki, A., Rashidi, N., Meybodi, H.A., et al. (2014) Metabolic Syndrome and Inflammatory Biomarkers in Adults: A Population-Based Survey in Western Region of Iran. International Cardiovascular Research Journal, 8, 156-160.
[28]
Chen, S.-J., Yen, C.-H., Huang, Y.-C., et al. (2012) Relationships between Inflammation, Adiponectin, and Oxidative Stress in Metabolic Syndrome. PLOS ONE, 7, e45693. https://doi.org/10.1371/journal.pone.0045693
[29]
Yilmaz, S.K., Eskici, G., Mertoglu, C. and Ayaz, A. (2021) Adipokines, Inflammation, Oxidative Stress: Critical Components in Obese Women with Metabolic Syndrome. Progress in Nutrition, 23, e2021009.
[30]
Sinatora, R.V., Chagas, E.F.B., Mattera, F.O.P., et al. (2022) Relationship of Inflammatory Markers and Metabolic Syndrome in Postmenopausal Women. Metabolites, 12, Article No. 73. https://doi.org/10.3390/metabo12010073
[31]
Pérez-Martínez, P., Mikhailidis, D.P., Athyros, V.G., Bullo, M., Couture, P., Covas, M.I., de Koning, L., Delgado-Lista, J., Diaz-Lopez, A. and Drevon, C.A. (2017) Lifestyle Recommendations for the Prevention and Management of Metabolic Syndrome: An International Panel Recommendation. Nutrition Reviews, 75, 307-326. https://doi.org/10.1093/nutrit/nux014
